AROMANOVA
AROMANOVA Tablet by NovaTech Sciences contains Exemestane (CAS 107868-30-4). Trusted manufacturer, supplier, and exporter of pharmaceutical-grade aromatase inhibitors for estrogen suppression and hormone balance.
CAS Number: 107868-30-4
AROMANOVA (Exemestane 25 mg) is an advanced aromatase inhibitor (AI) designed to reduce elevated estrogen levels. It helps control estrogen-related side effects such as gynecomastia, water retention, and hormonal imbalance during and after steroid cycles. Widely used in Post Cycle Therapy (PCT), Exemestane supports smoother hormone recovery by blocking estrogen conversion, ensuring optimal performance, lean muscle retention, and improved physique outcomes. Always use under professional supervision.
AROMANOVA by Nova Techsciences is a tablet formulation containing Exemestane 25 mg. Exemestane is a steroidal aromatase inhibitor identified by CAS Number 107868-30-4, molecular formula C20H24O2 and molecular weight of approximately 296.4 g/mol. It works by reducing the production of oestrogen through irreversible inhibition of the aromatase enzyme.
Exemestane is an established prescription medicine used in authorised settings for certain hormone-dependent breast cancers, particularly in postmenopausal patients. Its use must be based on an individual medical assessment and the approved prescribing information for the market in which it is supplied.
AROMANOVA Product Overview
Important product details include:
- Product name: AROMANOVA
- Active compound: Exemestane
- Strength: 25 mg per tablet
- Dosage form: Oral tablet
- CAS Number: 107868-30-4
- Brand: Nova Techsciences
The product label should clearly identify the complete formulation, inactive ingredients, tablet quantity, batch number, manufacturing date, expiry date and approved storage instructions. All information published online should remain consistent with the packaging, Certificate of Analysis and current regulatory documentation.
Quality and Product Traceability
Each AROMANOVA batch should be supported by appropriate quality-control records. These may include raw-material identification, active-ingredient assay, content-uniformity testing, dissolution assessment, impurity analysis, microbiological examination and packaging-integrity checks.
Nova Techsciences should publish claims relating to purity, manufacturing standards or pharmaceutical quality only when they can be supported by current documentation. For the United Kingdom and Netherlands, the product page should also state the applicable marketing-authorisation status, prescription category, responsible manufacturer and adverse-event reporting process.
Safety and Responsible Use
Exemestane can cause adverse effects such as hot flushes, tiredness, joint or muscle discomfort, headache, sleep disturbance and reduced bone-mineral density. Clinical monitoring may be required depending on the patient’s condition, treatment duration and other medicines being used.
AROMANOVA should not be used during pregnancy or breastfeeding and should not be taken for unsupervised hormone management, bodybuilding or post-cycle treatment. Patients should inform their healthcare professional about existing liver, kidney or bone conditions and all medicines or supplements they use.
Related Nova Techsciences Products
CABERNOVA
CABERNOVA contains Cabergoline 0.5 mg, identified by CAS Number 81409-90-7. Cabergoline is a dopamine agonist used in authorised clinical settings for disorders involving elevated prolactin. Its contraindications, cardiovascular precautions, interactions and monitoring requirements should be reviewed by a qualified prescriber.
CLOMINOVA
CLOMINOVA is presented as Clomiphene Citrate 50 mg, with CAS Number 50-41-9. Clomiphene is associated with medically supervised fertility treatment and requires appropriate assessment because it may affect vision, ovarian response and hormone-sensitive conditions.
ENCLOMINOVA
ENCLOMINOVA contains Enclomiphene Citrate 25 mg, identified by CAS Number 7599-79-3. It is chemically related to clomiphene but should be documented independently. Its legal and marketing-authorisation status must be confirmed for each country before supply or publication of therapeutic claims.
FEMANOVA
FEMANOVA contains Letrozole 2.5 mg, with CAS Number 112809-51-5. Letrozole is another aromatase inhibitor used in authorised hormone-dependent breast-cancer treatment and, in selected cases, specialist-managed fertility care. It is distinct from Exemestane and is not automatically interchangeable.
HALONOVA
HALONOVA contains Fluoxymesterone 5 mg, identified by CAS Number 76-43-7. Fluoxymesterone is an anabolic-androgenic medicine with significant liver, cardiovascular and hormonal safety considerations. It requires separate prescribing information, strict medical oversight and clear warnings against non-medical performance use.
AROMANOVA should ultimately be presented through accurate compound identification, balanced safety information, transparent batch documentation and clearly stated regulatory status.
Important Information & FAQs
Precautions & Contraindications
Precautions
- Always use AROMANOVA under the supervision of a qualified healthcare provider.
- Follow prescribed dosage and avoid self-medication.
- Inform your doctor about all medicines, supplements, or hormonal treatments.
- Keep out of reach of children; store in a cool, dry place.
- Avoid alcohol or substances that may interfere with hormonal therapy.
- Monitor for unusual symptoms such as severe fatigue, dizziness, or allergic reactions.
Contraindications
- Do not use if allergic to Exemestane or any inactive ingredient.
- Not for use in pregnant or breastfeeding women.
- Avoid in premenopausal women unless directed by a healthcare provider.
- Use with caution in individuals with severe liver or kidney disorders.
- Should not be combined with other medicines that strongly affect estrogen levels unless supervised by a medical professional.
Related Products
CABERNOVA
Premium Cabergoline tablets for prolactin control, hormone support, and enhanced recovery.
CLOMINOVA
Clomiphene Citrate 50 mg tablets for post-cycle therapy, testosterone recovery, and hormonal balance.
ENCLOMINOVA
Premium Enclomiphene Citrate tablets for testosterone boosting, PCT recovery, and hormonal balance.
FEMANOVA
High-purity aromatase inhibitor for reliable estrogen control.